US authorizes Pfizer pills to treat COVID-19

Plot of a novel coronavirus pandemic that spread from China

The FDA has approved Pfizer's COVID-19 Paxlovid pills, the Associated Press reports.

“ This decision gives a new tool for combating COVID-19 at a critical moment in a pandemic, during the emergence of new strains, and promises to make treatment more affordable for patients at high risk of severe COVID-19, '' & mdash; Patricia Cavazzoni, a spokeswoman for the evaluation and research of drugs, said in a statement.

It is noted that the Paxlovid drug will be the first pill for COVID-19 approved in the United States.

A company spokesman previously clarified that the tests new drugs are being carried out all over the world. In total, seven thousand people participate in them.

It is expected that by the end of this year, Pfizer will launch more than 180 thousand doses of the drug, and in 2022 – & mdash; will increase production to 50 million.

Paxlovid is developed both for the prevention of coronavirus infection and for the treatment of & nbsp; patients with high and medium risk of severe disease.


Leave a Comment